Visit the "Podcasts" section of jop.ascopubs.org and listen to two new items:

• "Barriers to Prescribing Crizotinib Following FDA Approval," by Robert S. Miller, MD, and Nathan A. Pennell, MD, PhD. Dr. Pennell discusses treating anaplastic lymphoma kinase–positive lung cancer in the weeks after the U.S. Food and Drug Administration approval of crizotinib. (Read the full JOP article.)
  
  
• "Rates of Screening for Hepatitis B Prior to Chemotherapy—Too Low?" by Robert S. Miller, MD, and Jessica P. Hwang, MD, MPH. Dr. Hwang discusses how she and her team sought to determine predictors of screening and positive hepatitis B virus test results in patients receiving chemotherapy. (Read the full JOP article.)